Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 97

1.

Losses of chromosome 5q and 14q are associated with favorable clinical outcome of patients with gastric cancer.

Buffart TE, Carvalho B, van Grieken NC, van Wieringen WN, Tijssen M, Kranenbarg EM, Verheul HM, Grabsch HI, Ylstra B, van de Velde CJ, Meijer GA.

Oncologist. 2012;17(5):653-62. doi: 10.1634/theoncologist.2010-0379.

2.

DNA copy number changes in gastric adenocarcinomas: high resolution-comparative genomic hybridization study in Turkey.

Gümüs-Akay G, Unal AE, Elhan AH, Bayar S, Karadayt K, Sunguroglu A, Kadikiran A, Tükün A.

Arch Med Res. 2009 Oct;40(7):551-60. doi: 10.1016/j.arcmed.2009.07.004.

PMID:
20082868
3.

Genetic alterations in primary gastric carcinomas correlated with clinicopathological variables by array comparative genomic hybridization.

Kang JU, Kang JJ, Kwon KC, Park JW, Jeong TE, Noh SM, Koo SH.

J Korean Med Sci. 2006 Aug;21(4):656-65.

4.

[Chromosomal alterations analyzed by comparative genomic hybridization in primary gastric carcinoma].

Zhu YQ, Zhu ZG, Liu BY, Chen XH, Yin HR, Wang XH.

Zhonghua Wei Chang Wai Ke Za Zhi. 2007 Mar;10(2):160-4. Chinese.

PMID:
17380459
5.

Genomic alterations in diffuse-type gastric cancer as shown by high-resolution comparative genomic hybridization.

Takeno SS, Leal MF, Lisboa LC, Lipay MV, Khayat AS, Assumpção PP, Burbano RR, Smith Mde A.

Cancer Genet Cytogenet. 2009 Apr 1;190(1):1-7. doi: 10.1016/j.cancergencyto.2008.09.007.

PMID:
19264226
6.

High expression of heat shock protein 90 is associated with tumor aggressiveness and poor prognosis in patients with advanced gastric cancer.

Wang J, Cui S, Zhang X, Wu Y, Tang H.

PLoS One. 2013 Apr 26;8(4):e62876. doi: 10.1371/journal.pone.0062876.

7.

Integration of DNA copy number alterations and transcriptional expression analysis in human gastric cancer.

Fan B, Dachrut S, Coral H, Yuen ST, Chu KM, Law S, Zhang L, Ji J, Leung SY, Chen X.

PLoS One. 2012;7(4):e29824. doi: 10.1371/journal.pone.0029824.

8.

Frequent gains of 20q and losses of 18q are associated with lymph node metastasis in intestinal-type gastric cancer.

Hidaka S, Yasutake T, Kondo M, Takeshita H, Yano H, Haseba M, Tsuji T, Sawai T, Nakagoe T, Tagawa Y.

Anticancer Res. 2003 Jul-Aug;23(4):3353-7.

PMID:
12926075
9.

Genomic profiling of submucosal-invasive gastric cancer by array-based comparative genomic hybridization.

Kuroda A, Tsukamoto Y, Nguyen LT, Noguchi T, Takeuchi I, Uchida M, Uchida T, Hijiya N, Nakada C, Okimoto T, Kodama M, Murakami K, Matsuura K, Seto M, Ito H, Fujioka T, Moriyama M.

PLoS One. 2011;6(7):e22313. doi: 10.1371/journal.pone.0022313.

10.

High resolution analysis of DNA copy-number aberrations of chromosomes 8, 13, and 20 in gastric cancers.

Buffart TE, van Grieken NC, Tijssen M, Coffa J, Ylstra B, Grabsch HI, van de Velde CJ, Carvalho B, Meijer GA.

Virchows Arch. 2009 Sep;455(3):213-23. doi: 10.1007/s00428-009-0814-y.

11.

Higher frequencies of numerical aberrations of chromosome 17 in primary gastric cancers are associated with lymph node metastasis.

Terada R, Yasutake T, Yamaguchi E, Hisamatsu T, Nakamura S, Ayabe H, Tagawa Y.

J Gastroenterol. 1999 Feb;34(1):11-7.

PMID:
10204605
12.

Chromosomal imbalances in gastric cancer. Correlation with histologic subtypes and tumor progression.

Noguchi T, Wirtz HC, Michaelis S, Gabbert HE, Mueller W.

Am J Clin Pathol. 2001 Jun;115(6):828-34. Review.

PMID:
11392878
13.

Association between HSP90 and Her2 in gastric and gastroesophageal carcinomas.

Berezowska S, Novotny A, Bauer K, Feuchtinger A, Slotta-Huspenina J, Becker K, Langer R, Walch A.

PLoS One. 2013 Jul 11;8(7):e69098. doi: 10.1371/journal.pone.0069098.

14.

Site-independent prognostic value of chromosome 9q loss in primary gastrointestinal stromal tumours.

Gunawan B, Schulten HJ, von Heydebreck A, Schmidt B, Enders C, Höer J, Langer C, Schüler P, Schindler CG, Kuhlgatz J, Füzesi L.

J Pathol. 2004 Apr;202(4):421-9.

PMID:
15095269
15.

High-level copy number gains of established and potential drug target genes in gastric cancer as a lead for treatment development and selection.

Labots M, Buffart TE, Haan JC, van Grieken NC, Tijssen M, van de Velde CJ, Grabsch HI, Ylstra B, Carvalho B, Fijneman RJ, Verheul HM, Meijer GA.

Cell Oncol (Dordr). 2014 Feb;37(1):41-52. doi: 10.1007/s13402-013-0162-4.

PMID:
24379144
16.

Genomic alterations in primary gastric adenocarcinomas correlate with clinicopathological characteristics and survival.

Weiss MM, Kuipers EJ, Postma C, Snijders AM, Pinkel D, Meuwissen SG, Albertson D, Meijer GA.

Cell Oncol. 2004;26(5-6):307-17.

17.

Genomic instability and DNA ploidy are linked to DNA copy number aberrations of 8p23 and 22q11.23 in gastric cancers.

Kawauchi S, Furuay T, Uchiyama T, Adachi A, Okada T, Nakao M, Oga A, Uchida K, Sasaki K.

Int J Mol Med. 2010 Sep;26(3):333-9.

PMID:
20664948
18.

Comparative study between DNA copy number aberrations determined by quantitative microsatellite analysis and clinical outcome in patients with stomach cancer.

Suzuki S, Egami K, Sasajima K, Ghazizadeh M, Shimizu H, Watanabe H, Hasegawa H, Iida S, Matsuda T, Okihama Y, Hosone M, Shimizu K, Kawanami O, Tajiri T.

Clin Cancer Res. 2004 May 1;10(9):3013-9.

19.
20.

DNA copy number profiles of gastric cancer precursor lesions.

Buffart TE, Carvalho B, Mons T, Reis RM, Moutinho C, Silva P, van Grieken NC, Vieth M, Stolte M, van de Velde CJ, Schrock E, Matthaei A, Ylstra B, Carneiro F, Meijer GA.

BMC Genomics. 2007 Oct 1;8:345.

Supplemental Content

Support Center